Logo Prima Biomed

Welcome to the Newsroom

25 September 2015

Prima BioMed to present at Leerink Partners Rare Disease Roundtable


SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, the “Company”), a leading immuno-oncology company, announces that Marc Voigt, CEO, will present an overview of the company at the LEERINK Partners 4th Annual Rare Disease Roundtable. This one-day event will be held atLe Parker Meridien in New York City on Wednesday, September 30, 2015. Mr Voigt’s presentation will be at 1:20 PM (U.S. Eastern Standard Time).